Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Dose-Escalated Radiation Alone or in Combination With Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes From NRG/Radiation Therapy Oncology Group 0815 Randomized Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 27, 2023
Normal Tissue Integral Dose as a Result of Prostate Radiation Therapy: A Quantitative Comparison Between High-Dose-Rate Brachytherapy and Modern External Beam Radiation Therapy Techniques.
Journal: Advances in radiation oncology
Published: May 27, 2022
Evaluation of VMAT Planning Strategies for Prostate Patients with Bilateral Hip Prosthesis.
Journal: Technology in cancer research & treatment
Published: September 07, 2021
Quality of Life Implications of Dose-Escalated External Beam Radiation for Localized Prostate Cancer: Results of a Prospective Randomized Phase 3 Clinical Trial, NRG/RTOG 0126.
Journal: International journal of radiation oncology, biology, physics
Published: February 11, 2021
Long-Term Results of NRG Oncology/RTOG 0321: A Phase II Trial of Combined High Dose Rate Brachytherapy and External Beam Radiation Therapy for Adenocarcinoma of the Prostate.
Journal: International journal of radiation oncology, biology, physics
Published: April 16, 2020
Rates of rectal toxicity in patients treated with high dose rate brachytherapy as monotherapy compared to dose-escalated external beam radiation therapy for localized prostate cancer.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: November 10, 2019
Five-Year Outcomes of a Single-Institution Prospective Trial of 19-Gy Single-Fraction High-Dose-Rate Brachytherapy for Low- and Intermediate-Risk Prostate Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: November 14, 2018
Cost-effectiveness of prostate boost with high-dose-rate brachytherapy versus intensity-modulated radiation therapy in the treatment of intermediate-high risk prostate cancer.
Journal: Brachytherapy
Published: May 01, 2018
Outcomes and toxicity from a prospective study of moderately hypofractionated radiation therapy for prostate cancer.
Journal: Advances in radiation oncology
Published: August 10, 2017
ACR Appropriateness Criteria for external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II.
Journal: Advances in radiation oncology
Published: January 26, 2017
ACR Appropriateness Criteria® Locally Advanced, High-Risk Prostate Cancer.
Journal: American journal of clinical oncology
Published: January 07, 2017
ACR appropriateness criteria: Permanent source brachytherapy for prostate cancer.
Journal: Brachytherapy
Published: September 22, 2016
Last Updated: 09/26/2026